X0306 4 2020-12-11 0000070318 TENET HEALTHCARE CORP THC 0001138995 GLENVIEW CAPITAL MANAGEMENT, LLC 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 true 0001228603 ROBBINS LARRY 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 true Common Stock, $0.05 par value 2020-12-11 4 S 0 491663 40.6712 D 19217296 I See footnotes Common Stock, $0.05 par value 2020-12-11 4 S 0 8337 41.9986 D 19208959 I See footnotes Common Stock, $0.05 par value 2020-12-14 4 S 0 201903 40.2196 D 19007056 I See footnotes Common Stock, $0.05 par value 2020-12-14 4 S 0 129026 41.0551 D 18878030 I See footnotes Common Stock, $0.05 par value 2020-12-14 4 S 0 29787 42.0931 D 18848243 I See footnotes Common Stock, $0.05 par value 2020-12-15 4 S 0 152267 41.2688 D 18695976 I See footnotes Common Stock, $0.05 par value 2020-12-15 4 S 0 187017 42.3117 D 18508959 I See footnotes Common Stock, $0.05 par value 52394 D These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 11, 2020 within a $1.00 range. The actual prices for these transactions range from $40.405 to $41.36, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 11, 2020 within a $1.00 range. The actual prices for these transactions range from $41.50 to $42.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 14, 2020 within a $1.00 range. The actual prices for these transactions range from $39.83 to $40.80, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 14, 2020 within a $1.00 range. The actual prices for these transactions range from $40.85 to $41.30, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 14, 2020 within a $1.00 range. The actual prices for these transactions range from $42.01 to $42.1825, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 15, 2020 within a $1.00 range. The actual prices for these transactions range from $41.00 to $41.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 15, 2020 within a $1.00 range. The actual prices for these transactions range from $42.20 to $42.62, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. These 52,394 Shares reflect restricted stock units ("RSUs") that have all previously been settled into Shares. Each RSU is the economic equivalent of one Share. Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13D filed by the Reporting Persons on January 19, 2016 is incorporated herein by reference. /s/ Mark J. Horowitz, Co-President of Glenview Capital Management, LLC 2020-12-15 /s/ Mark J. Horowitz, attorney-in-fact for Larry Robbins 2020-12-15